Japan Medical Dynamic Marketing (TSE:7600) Cyclically Adjusted Revenue per Share: 円795.58 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7600 Japan Medical Dynamic Marketing Inc TSE:7600
80 GF Score
Price 円900.00
GF Value 円641.57
Valuation Significantly Overvalued
! 12 Warning Signs
View Full Analysis

What is Japan Medical Dynamic Marketing Cyclically Adjusted Revenue per Share?

Japan Medical Dynamic Marketing TSE:7600 -1.85% 80 Cyclically Adjusted Revenue per Share is 円795.58 as of Mar. 2026. GuruFocus rates TSE:7600 with a GF Score™ of 80/100 and a GF Value™ of 円641.57 (Significantly Overvalued). The stock has 12 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Japan Medical Dynamic Marketing's adjusted revenue per share for the three months ended in Mar. 2026 was 円227.281. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円795.58 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Japan Medical Dynamic Marketing's average Cyclically Adjusted Revenue Growth Rate was 6.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Japan Medical Dynamic Marketing was 11.00% per year. The lowest was 6.60% per year. And the median was 9.00% per year.

As of today (2026-07-25), Japan Medical Dynamic Marketing's current stock price is 円900.00. Japan Medical Dynamic Marketing's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was 円795.58. Japan Medical Dynamic Marketing's Cyclically Adjusted PS Ratio of today is 1.13.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Japan Medical Dynamic Marketing was 5.40. The lowest was 0.61. And the median was 2.31.


Japan Medical Dynamic Marketing  (TSE:7600) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Japan Medical Dynamic Marketing's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=900.00/795.58
=1.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Japan Medical Dynamic Marketing was 5.40. The lowest was 0.61. And the median was 2.31.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Japan Medical Dynamic Marketing Cyclically Adjusted Revenue per Share Related Terms


Japan Medical Dynamic Marketing Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Japan Medical Dynamic Marketing's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Japan Medical Dynamic Marketing Cyclically Adjusted Revenue per Share Chart

Japan Medical Dynamic Marketing Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 549.20 614.70 679.72 750.21 795.58

Japan Medical Dynamic Marketing Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 750.21 763.66 773.88 790.41 795.58

TSE:7600 vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Japan Medical Dynamic Marketing's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Japan Medical Dynamic Marketing Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Japan Medical Dynamic Marketing's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Japan Medical Dynamic Marketing's Cyclically Adjusted PS Ratio falls into.


TSE:7600
80GF Score
Japan Medical Dynamic Marketing Inc TSE:7600
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Japan Medical Dynamic Marketing Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Japan Medical Dynamic Marketing's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=227.281/112.7000*112.7000
=227.281

Current CPI (Mar. 2026) = 112.7000.

Japan Medical Dynamic Marketing Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 122.064 98.100 140.231
201609 119.652 98.000 137.600
201612 132.483 98.400 151.736
201703 141.195 98.100 162.209
201706 127.639 98.500 146.040
201709 122.902 98.800 140.193
201712 152.692 99.400 173.123
201803 157.659 99.200 179.115
201806 142.547 99.200 161.946
201809 143.468 99.900 161.850
201812 170.092 99.700 192.270
201903 177.539 99.700 200.689
201906 165.302 99.800 186.669
201909 167.367 100.100 188.434
201912 178.953 100.500 200.677
202003 173.427 100.300 194.868
202006 129.209 99.900 145.764
202009 164.645 99.900 185.741
202012 172.670 99.300 195.971
202103 167.882 99.900 189.392
202106 171.990 99.500 194.807
202109 163.763 100.100 184.377
202112 194.043 100.100 218.468
202203 197.641 101.100 220.318
202206 190.548 101.800 210.950
202209 188.076 103.100 205.588
202212 213.580 104.100 231.224
202303 216.043 104.400 233.219
202306 205.416 105.200 220.061
202309 210.834 106.200 223.738
202312 229.411 106.800 242.084
202403 234.812 107.200 246.859
202406 229.903 108.200 239.465
202409 218.914 108.900 226.553
202412 252.208 110.700 256.765
202503 252.722 111.100 256.362
202506 224.672 111.700 226.683
202509 216.028 112.000 217.378
202512 239.776 113.000 239.139
202603 227.281 112.700 227.281

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of 円795.58 mean?
Japan Medical Dynamic Marketing (TSE:7600) has a Cyclically Adjusted Revenue per Share of 円795.58 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Japan Medical Dynamic Marketing and its competitors.
Is Japan Medical Dynamic Marketing's Cyclically Adjusted Revenue per Share too high?
Japan Medical Dynamic Marketing's current Cyclically Adjusted Revenue per Share is 円795.58. Overall, Japan Medical Dynamic Marketing has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Japan Medical Dynamic Marketing's Cyclically Adjusted Revenue per Share compare to ABT and SYK?
Japan Medical Dynamic Marketing's Cyclically Adjusted Revenue per Share of 円795.58 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Japan Medical Dynamic Marketing and its competitors. Japan Medical Dynamic Marketing's current Cyclically Adjusted Revenue per Share is 円795.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Medical Dynamic Marketing stock overvalued right now?
Based on GuruFocus' analysis, Japan Medical Dynamic Marketing (TSE:7600) is currently considered Significantly Overvalued. The stock's GF Value™ is 円641.57, compared to a current price of 円900.00 — trading 40.3% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is 円795.58. Japan Medical Dynamic Marketing's overall GF Score™ is 80/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Japan Medical Dynamic Marketing (TSE:7600), the current Cyclically Adjusted Revenue per Share is 円795.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Japan Medical Dynamic Marketing (TSE:7600) Overvalued in 2026?

Based on GuruFocus' analysis, Japan Medical Dynamic Marketing stock appears to be overvalued. The current stock price of 円900.00 is trading 40.3% above its estimated GF Value™ of 円641.57. GuruFocus considers Japan Medical Dynamic Marketing to be Significantly Overvalued.

Key valuation signals for TSE:7600:

  • Cyclically Adjusted Revenue per Share: 円795.58
  • GF Value™: 円641.57 vs. price of 円900.00 (40.3% above fair value)
  • GF Score™: 80/100 with 12 warning signs

No single metric tells the full story. See the TSE:7600 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Japan Medical Dynamic Marketing Business Description

Other Exchanges JMDMF:USA
Address 12-2, Ichigayadaimachi, Shinjuku-ku, Tokyo, JPN, 162-0066
Japan Medical Dynamic Marketing Inc is a Japan-based medical equipment manufacturer. The company is engaged in the development and sale of advanced medical devices. Products offered by the company include trauma devices, joint prostheses, spinal fixation devices, and artificial bone fillers. It caters its products to medical professionals and major hospitals throughout Japan. The company is also engaged in the import and sale of medical devices.
80GF Score

Get the complete analysis for TSE:7600

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円900.00
Price
円641.57
GF Value